Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bosco Paes

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Infectious Diseases and Therapy|August 3, 2016
Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western CountriesLouis Bont, Paul A Checchia, Brigitte Fauroux, et al.
Infectious Diseases and Therapy|June 28, 2017
Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic DiseasesPaolo Manzoni, Josep Figueras-Aloy, Eric A F Simões, et al.
Infectious Diseases and Therapy|September 16, 2016
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart DiseaseJosep Figueras-Aloy, Paolo Manzoni, Bosco Paes, et al.
Infectious Diseases and Therapy|January 11, 2017
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart DiseasePaul A Checchia, Bosco Paes, Louis Bont, et al.
Pediatrics|May 7, 2014
Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort studyHao Yi, Krista L Lanctôt, Louis Bont, et al.
Transfusion|July 23, 2013
Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulinTamam Bakchoul, Dirk Bassler, Matthias Heckmann, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|April 11, 2025
Optimizing risk factors to guide COST-effective use of palivizumab in KOREAN infantsJi-Man Kang, Xavier Carbonell-Estrany, Bosco Paes, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2008
Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestationJohn S Sampalis, Joanne Langley, Xavier Carbonell-Estrany, et al.
Paediatric Respiratory Reviews|May 8, 2019
Expert consensus on palivizumab use for respiratory syncytial virus in developed countriesManuel Sánchez Luna, Paolo Manzoni, Bosco Paes, et al.
Blood|January 13, 2006
Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT)Volker Kiefel, Dirk Bassler, Hartmut Kroll, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Infectious Diseases and Therapy|August 3, 2016
Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western CountriesLouis Bont, Paul A Checchia, Brigitte Fauroux, et al.
Infectious Diseases and Therapy|June 28, 2017
Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic DiseasesPaolo Manzoni, Josep Figueras-Aloy, Eric A F Simões, et al.
Infectious Diseases and Therapy|September 16, 2016
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart DiseaseJosep Figueras-Aloy, Paolo Manzoni, Bosco Paes, et al.
Infectious Diseases and Therapy|January 11, 2017
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart DiseasePaul A Checchia, Bosco Paes, Louis Bont, et al.
Pediatrics|May 7, 2014
Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort studyHao Yi, Krista L Lanctôt, Louis Bont, et al.
Transfusion|July 23, 2013
Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulinTamam Bakchoul, Dirk Bassler, Matthias Heckmann, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|April 11, 2025
Optimizing risk factors to guide COST-effective use of palivizumab in KOREAN infantsJi-Man Kang, Xavier Carbonell-Estrany, Bosco Paes, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2008
Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestationJohn S Sampalis, Joanne Langley, Xavier Carbonell-Estrany, et al.
Paediatric Respiratory Reviews|May 8, 2019
Expert consensus on palivizumab use for respiratory syncytial virus in developed countriesManuel Sánchez Luna, Paolo Manzoni, Bosco Paes, et al.
Blood|January 13, 2006
Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT)Volker Kiefel, Dirk Bassler, Hartmut Kroll, et al.
Pageof 12